These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26580122)

  • 1. Exploration of gated ligand binding recognizes an allosteric site for blocking FABP4-protein interaction.
    Li Y; Li X; Dong Z
    Phys Chem Chem Phys; 2015 Dec; 17(48):32257-67. PubMed ID: 26580122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerted dynamic motions of an FABP4 model and its ligands revealed by microsecond molecular dynamics simulations.
    Li Y; Li X; Dong Z
    Biochemistry; 2014 Oct; 53(40):6409-17. PubMed ID: 25231537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4.
    Ayers SD; Nedrow KL; Gillilan RE; Noy N
    Biochemistry; 2007 Jun; 46(23):6744-52. PubMed ID: 17516629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for activation of fatty acid-binding protein 4.
    Gillilan RE; Ayers SD; Noy N
    J Mol Biol; 2007 Oct; 372(5):1246-60. PubMed ID: 17761196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free-energy landscapes of ion-channel gating are malleable: changes in the number of bound ligands are accompanied by changes in the location of the transition state in acetylcholine-receptor channels.
    Grosman C
    Biochemistry; 2003 Dec; 42(50):14977-87. PubMed ID: 14674774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
    Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
    Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.
    Temma T; Nishigori K; Onoe S; Sampei S; Kimura I; Ono M; Saji H
    Nucl Med Biol; 2015 Feb; 42(2):184-91. PubMed ID: 25457456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis and molecular characterization of genomic sequences and proteins of FABP4 and FABP5 from the giant panda (Ailuropoda melanoleuca).
    Song B; Hou YL; Ding X; Wang T; Wang F; Zhong JC; Xu T; Zhong J; Hou WR; Shuai SR
    Genet Mol Res; 2014 Feb; 13(1):992-1004. PubMed ID: 24634121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Virtual Screening and Substructure Search for Discovery of Novel FABP4 Inhibitors.
    Cai H; Wang T; Yang Z; Xu Z; Wang G; Wang HY; Zhu W; Chen K
    J Chem Inf Model; 2017 Sep; 57(9):2329-2335. PubMed ID: 28810126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4).
    González JM; Fisher SZ
    Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):163-70. PubMed ID: 25664790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of direct competition and allosteric modulation of small-molecular-weight protein ligands using surface plasmon resonance methods.
    Huber W; Sinopoli A; Kohler J; Hug M; Ruf A; Huber S
    J Mol Recognit; 2015 Aug; 28(8):480-91. PubMed ID: 25763559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
    Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
    Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into ligand binding features of dual FABP4/5 inhibitors by molecular dynamics simulations.
    Wu W; Han L; Wang C; Wen X; Sun H; Yuan H
    J Biomol Struct Dyn; 2019 Nov; 37(18):4790-4800. PubMed ID: 30590992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FABP4 reversed the regulation of leptin on mitochondrial fatty acid oxidation in mice adipocytes.
    Gan L; Liu Z; Cao W; Zhang Z; Sun C
    Sci Rep; 2015 Aug; 5():13588. PubMed ID: 26310911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational kinetics reveals affinities of protein conformational states.
    Daniels KG; Suo Y; Oas TG
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9352-7. PubMed ID: 26162682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages.
    Lázaro I; Ferré R; Masana L; Cabré A
    Atherosclerosis; 2013 Oct; 230(2):216-22. PubMed ID: 24075747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coarse-grained molecular simulations of allosteric cooperativity.
    Nandigrami P; Portman JJ
    J Chem Phys; 2016 Mar; 144(10):105101. PubMed ID: 26979705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of monoclonal antibodies against FABP4.
    Gorbenko O; Filonenko V; Gout I
    Hybridoma (Larchmt); 2006 Apr; 25(2):86-90. PubMed ID: 16704309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.
    Beniyama Y; Matsuno K; Miyachi H
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1662-6. PubMed ID: 23395658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.